Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase-II Study Evaluating Midostaurin in Induction, Consolidation and Maintenance Therapy Also After Allogeneic Blood Stem Cell Transplantation in Patients With Newly Diagnosed Acute Myeloid Leukemia Exhibiting a FLT3 Internal Tandem Duplication

NCT01477606 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT01477606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01477606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase-II Study Evaluating Midostaurin in Induction, Consolidation and Maintenance Therapy Also After Allogeneic Blood Stem Cell Transplantation in Patients With Newly Diagnosed Acute Myeloid Leukemia Exhibiting a FLT3 Internal Tandem Duplication
Lead sponsor
University of Ulm
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
February 26, 2020
Enrollment
451 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia